Mining New RNA Science for Clinical Promise
Last year in Christopher Holley’s lab, an uninstalled exhaust hood still wrapped in plastic suggested that the young investigator was just getting going.
Don’t be deceived. Holley arrived a lab-bench veteran when he joined Duke’s cardiology division faculty in 2015. But the physician-scientist is launching something very new: wide-reaching molecular studies into a new field of RNA biology with vast potential.
Welcome new hospitalists
DGIM is proud to announce two new hospitalists join our division this month!
Schulman in The Hill: 'Here's what's in store for 2018 health care'
Dr. Kevin Schulman was once again published in The Hill, an American political journalism newspaper and website published in Washington, DC.
Funding opp: Duke CTSI Community Engagement Population Health Improvement Awards
The Duke CTSI Community Engagement Population Health Improvement Awards program will provide approximately $200,000 for direct costs to support pilot awards that can be used to either a) develop new community-research partnerships or b) foment already existing community and research partnerships that aim to develop and test effective solutions to improve community and population health. Deadline is Feb. 22, 2018.
Funding opp: Duke Incubation Fund supports early-state ideas
The Duke Innovation & Entrepreneurship Initiative is accepting applications for the Duke Incubation Fund, to support early-stage ideas based on Duke intellectual property with the potential to go to market and impact society. Deadline for applications is Jan. 8, 2018.
Medicine and Surgery get moving with 10-week step counting challenge
On Jan. 8, the Department of Medicine and Department of Surgery will begin a 10-week competition to see which department can move the most in 2018.
Internal Medicine Residency News, Jan. 2, 2018
Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for Jan. 2, 2018.
Recent DGIM Promotions
We are proud to announce 4 faculty members have been promoted to Assistant Professor this month!
Pharmacology Studies Fuel a Quest to Shed Drug Side Effects
In clinic, cardiologist Sudarshan Rajagopal, MD, PhD, has no means to cure most patients with pulmonary hypertension, not the narrowing of blood vessels in their lungs, not damage done to their hearts.
The physician-scientist can prescribe medicines that extend the lives of many patients, but the precious gains can come with unwelcome costs.
“All these drugs help open blood vessels in the lungs and help treat heart failure. But they can have horrible side effects,” Rajagopal says, including nausea, diarrhea, weight loss and other side effects.
But help may come from complex pharmacology studies that Rajagopal first encountered at Duke in the laboratory of Nobel Prize winner Robert Lefkowitz, MD.